Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting TBK1 to overcome resistance to cancer immunotherapy
Yi Sun, Or‐Yam Revach, Seth Anderson, et al.
Nature (2023) Vol. 615, Iss. 7950, pp. 158-167
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 45
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities
Mona Meng Wang, Sarah E. Coupland, Tero Aittokallio, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 8, pp. 1212-1224
Open Access | Times Cited: 44
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
Roel Polak, Elisa T. Zhang, Calvin J. Kuo
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 523-539
Closed Access | Times Cited: 43
Pan-cancer proteogenomics characterization of tumor immunity
Francesca Petralia, Weiping Ma, Tomer M. Yaron, et al.
Cell (2024) Vol. 187, Iss. 5, pp. 1255-1277.e27
Open Access | Times Cited: 32
Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma
Justin Low, Michael C. Brown, Zachary J. Reitman, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 2
Open Access | Times Cited: 16
Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death
Jarama Clucas, Pascal Meier
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 11, pp. 835-852
Closed Access | Times Cited: 31
A Review of Current and Pipeline Drugs for Treatment of Melanoma
Nicole Natarelli, Soo Aleman, Isabella Mark, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 214-214
Open Access | Times Cited: 14
Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research
Juliana Santos Rosa Viegas, Bruno Sarmento
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115295-115295
Open Access | Times Cited: 11
Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression
Jong Ho Park, Mahsa Mortaja, Heehwa G. Son, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Emerging roles of TBK1 in cancer immunobiology
Alex Miranda, Carl A. Shirley, Russell W. Jenkins
Trends in cancer (2024)
Closed Access | Times Cited: 8
Role of the tumor microenvironment in malignant melanoma organoids during the development and metastasis of tumors
Siyu Zhou, Jinghan Lu, Shiyang Liu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 17
TANK-Binding Kinase 1 in the Pathogenesis and Treatment of Inflammation-Related Diseases
Hui Lü, Xiaolin Chen, Mengke Huang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1941-1941
Open Access
Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy
Jesse Boumelha, Míriam Molina‐Arcas, Julian Downward
Clinical Cancer Research (2023) Vol. 29, Iss. 24, pp. 5012-5020
Open Access | Times Cited: 14
Identification of High-Affinity Inhibitors of TANK-Binding Kinase 1 (TBK1): A Promising Frontier for Controlling Inflammatory Signaling in Cancer
Deeba Shamim Jairajpuri, Taj Mohammad, Afzal Hussain, et al.
Discovery Medicine (2024) Vol. 36, Iss. 180, pp. 129-129
Open Access | Times Cited: 4
Targeting TANK-binding kinase 1 attenuates painful diabetic neuropathy via inhibiting microglia pyroptosis
Qinming Liao, Yimei Yang, Yilu Li, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Organoids in skin wound healing
Zitong Wang, Feng Zhao, Hongxin Lang, et al.
Burns & Trauma (2025) Vol. 13
Open Access
TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Yi Sun, Luke Maggs, Apekshya Panda, et al.
Cancer Immunology Research (2025) Vol. 13, Iss. 2, pp. 210-228
Closed Access
Tumor organoids in cancer medicine: from model systems to natural compound screening
Rong Cong, Can Lu, Xinying Li, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 89-109
Open Access
TBK1 and IKKε prevent premature cell death by limiting the activity of both RIPK1 and NLRP3 death pathways
Fabian A. Fischer, Benjamin Demarco, Felicia Chan Hui Min, et al.
Science Advances (2025) Vol. 11, Iss. 10
Open Access
Adapting systems biology to address the complexity of human disease in the single-cell era
David S. Fischer, Martin Arreola Villanueva, Peter Winter, et al.
Nature Reviews Genetics (2025)
Closed Access
VDAC2 loss elicits tumour destruction and inflammation for cancer therapy
Sujing Yuan, Renqiang Sun, Hao Shi, et al.
Nature (2025)
Open Access
TBK1 is a signaling hub in coordinating stress-adaptive mechanisms in head and neck cancer progression
Hyo Jeong Kim, Haeng‐Jun Kim, Sunyong Kim, et al.
Autophagy (2025)
Open Access
Transforming cancer treatment: integrating patient-derived organoids and CRISPR screening for precision medicine
Ziyi Zhu, John Paul Shen, Paul Chi-Lui Ho, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Mutational Profile of Blood and Tumor Tissue and Biomarkers of Response to PD-1 Inhibitors in Patients with Cutaneous Squamous Cell Carcinoma
Mark J. Chang, Daniel B. Stamos, Cetin Urtis, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1172-1172
Open Access
Structure-Based Optimization of TBK1 Inhibitors
Wenxuan Sun, Yuting Xie, Qiancheng Xia, et al.
ACS Medicinal Chemistry Letters (2025)
Closed Access
Page 1 - Next Page

Scroll to top